Market revenue in 2023 | USD 6.2 million |
Market revenue in 2030 | USD 17.3 million |
Growth rate | 15.8% (CAGR from 2023 to 2030) |
Largest segment | Commercial |
Fastest growing segment | Commercial |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical, Preclinical, Commercial |
Key market players worldwide | Roche, Wuxi AppTec Co Ltd, Pfizer Inc, Astellas Pharma Inc, Lifespan, Genscript Biotech Corp Class H, Biomarin Pharmaceutical Inc, Oxford Biomedical Research, Sarepta Therapeutics Inc, YposKesi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to adeno associated virus vector manufacturing market will help companies and investors design strategic landscapes.
Commercial was the largest segment with a revenue share of 54.84% in 2023. Horizon Databook has segmented the Argentina adeno associated virus vector manufacturing market based on clinical, preclinical, commercial covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina adeno associated virus vector manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Argentina adeno associated virus vector manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account